Molecular SPECT Imaging: An Overview
- PMID: 21603240
- PMCID: PMC3094893
- DOI: 10.1155/2011/796025
Molecular SPECT Imaging: An Overview
Abstract
Molecular imaging has witnessed a tremendous change over the last decade. Growing interest and emphasis are placed on this specialized technology represented by developing new scanners, pharmaceutical drugs, diagnostic agents, new therapeutic regimens, and ultimately, significant improvement of patient health care. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) have their signature on paving the way to molecular diagnostics and personalized medicine. The former will be the topic of the current paper where the authors address the current position of the molecular SPECT imaging among other imaging techniques, describing strengths and weaknesses, differences between SPECT and PET, and focusing on different SPECT designs and detection systems. Radiopharmaceutical compounds of clinical as well-preclinical interest have also been reviewed. Moreover, the last section covers several application, of μSPECT imaging in many areas of disease detection and diagnosis.
Figures
References
-
- Von Schulthess GK, Schlemmer HPW. A look ahead: PET/MR versus PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 2009;36(supplement 1):S3–S9. - PubMed
-
- Douraghy A, Chatziioannou AF. Preclincal imaging. In: Khalil M, editor. Basic Sciences of Nuclear Medicine. chapter 18. New York, NY, USA: Springer; 2011.
-
- Phelps ME. PET: the merging of biology and imaging into molecular imaging. Journal of Nuclear Medicine. 2000;41(4):661–681. - PubMed
-
- Meikle SR, Kench P, Kassiou M, Banati RB. Small animal SPECT and its place in the matrix of molecular imaging technologies. Physics in Medicine and Biology. 2005;50(22):R45–R61. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
